Dr. Rizo brings extensive industry leadership experience to Vividion, having held multiple senior executive roles during her career at both biotechnology and large pharmaceutical companies.
Most recently, she served as chief human resources officer at Vyripharm Enterprises.
Guindo will be responsible for leading the development and implementation of the company’s long-term strategy for the Human Health portfolio.
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
Gilman will be responsible for all business development and portfolio strategy efforts globally.
Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.
Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.
Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA
AstraZeneca also played a critical role in the global response to COVID-19.
The refocused commercial set-up will increase organizational efficiency and alignment across all commercial functions globally
Subscribe To Our Newsletter & Stay Updated
